EP2077750A2 - Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané - Google Patents

Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané

Info

Publication number
EP2077750A2
EP2077750A2 EP07863843A EP07863843A EP2077750A2 EP 2077750 A2 EP2077750 A2 EP 2077750A2 EP 07863843 A EP07863843 A EP 07863843A EP 07863843 A EP07863843 A EP 07863843A EP 2077750 A2 EP2077750 A2 EP 2077750A2
Authority
EP
European Patent Office
Prior art keywords
sample
signal
sample probe
optical
contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07863843A
Other languages
German (de)
English (en)
Other versions
EP2077750A4 (fr
Inventor
Timothy L. Ruchti
James M. Welch
Christopher Slawinski
Thomas B. Blank
Stephen L. Monfre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sensys Medical Inc
Original Assignee
Sensys Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sensys Medical Inc filed Critical Sensys Medical Inc
Publication of EP2077750A2 publication Critical patent/EP2077750A2/fr
Publication of EP2077750A4 publication Critical patent/EP2077750A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843—Monitoring or controlling sensor contact pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/14—Coupling media or elements to improve sensor contact with skin or tissue
    • A61B2562/146—Coupling media or elements to improve sensor contact with skin or tissue for optical coupling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0531—Measuring skin impedance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02—Details
    • G01J3/0205—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows
    • G01J3/0218—Optical elements not provided otherwise, e.g. optical manifolds, diffusers, windows using optical fibers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02—Details
    • G01J3/027—Control of working procedures of a spectrometer; Failure detection; Bandwidth calculation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
    • G01J3/02—Details
    • G01J3/0278—Control or determination of height or angle information for sensors or receivers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light

Definitions

  • the invention relates to a method and apparatus for performing noninvasive analyte property determination. More particularly, the invention relates to determining proximity and/or contact of an optical sample probe with skin tissue.
  • Spectroscopy based noninvasive analyzers deliver external energy in the form of light to a sample site, region, or volume of a human body where the photons interact with a tissue sample, thus probing chemical and physical features. Some of the incident photons are specularly reflected, diffusely reflected, scattered, and/or transmitted out of the body where they are detected. An algorithm is used to determine a property of the body using knowledge of the detected photons.
  • noninvasive analyzers are analyzer based upon: magnetic resonance imaging (MRI's); X- rays; and those based upon visible, near-infrared, and/or infrared light.
  • Noninvasive ⁇ sampling a deformable object is complicated by optical and mechanical mechanisms occurring before and/or during sampling.
  • the analytical signal is strong, where strong refers to a signal that is visibly observed in a spectrum after signal processing.
  • a pulse oximeter uses the relatively large oxy- and deoxyhemoglobin signals in a matrix having relatively few interferences. In this case, the applied pressure at the sample site is tolerated by the measurement due to the relatively large analytical signal of hemoglobin and deoxyhemoglobin used in determination of the oxygen concentration.
  • the analytical signal measured by a noninvasive analyzer is relatively weak, where a weak signal is not visibly observed in a spectrum after signal processing and requires multivariate analysis in order to resolve a spectral response to the analyte due to the presence of multiple interferences where at least one interference is spectrally more intense than the analytical signal of interest.
  • a noninvasive glucose concentration analyzer using mid- or near-infrared glucose absorbance bands from 1100 to 2500 nm, relies on relatively small analytical signals that are often present amongst a multitude of interfering signals and uses a plurality of wavelengths, such as three, four, or more wavelengths. In this later case, perturbation of the sample by the noninvasive analyzer degrades analytical performance of the analyzer.
  • the second class of noninvasive analyzers optionally sample without contacting the sample.
  • specular reflectance and/or stray light often substantially degrades the analytical signal.
  • Optomechanical approaches designed to minimize reduction of detected specularly reflected light are hindered by that fact that skin diffusely scatters light.
  • algorithms used to reduce the effects of specular reflectance are complicated by specularly reflected light contributing in an additive manner to the resultant spectrum. The additive contribution results in a nonlinear interference, which results in a distortion of the spectrum that is difficult to remove.
  • the problem of the relatively large specularly reflected light is greatly enhanced as the magnitude of the analyte signal decreases.
  • specularly reflected light is preferably avoided.
  • an analyte property such as glucose or urea concentration
  • the second class of noninvasive analyzers contact the sample before and/or during sampling.
  • an optical probe of the analyzer deforms the sample upon contact with the sample.
  • the optical properties of the sample are changed due to contact, such as contact with an optical sample probe.
  • Changed optical properties due to movement of a sample before or during sampling include:
  • the deformation of the sample with the resulting change in optical properties of the sample is often detrimental.
  • the changes in the sample resulting from sampling degrade resulting analyte property determination.
  • the relative changes in the sample due to sampling result in increasing difficulty in extraction of analyte signal.
  • the sampling induced changes preclude precise and/or accurate analyte property determination from a sample spectrum.
  • a sample probe contacting skin of a human alters the sample. Changes to the skin sample upon contact, during sampling, and/or before sampling include: • stretching of skin;
  • the changes are often time dependent and methodology of sampling dependent.
  • the degree of contact to the sample by the spectrometer results in nonlinear changes to a resulting collected spectrum.
  • manually manipulating a spectrometer during optical sampling relies upon human dexterity, attentiveness, and training. Humans are limited in terms of dexterity, precision, reproducibility of movement, and sight. For example, placing a spectrometer in contact with an object during sampling is complicated by a number of parameters including any of:
  • NONINVASIVE TECHNOLOGIES There are a number of reports on noninvasive glucose technologies. Some of these relate to general instrumentation configurations, such as those required for noninvasive glucose concentration estimation, while others refer to sampling technologies. Those related to the present invention are briefly reviewed here:
  • 6,040,578 (March 21 , 2000) describe a method and apparatus for determination of an organic blood analyte using multi-spectral analysis in the near-infrared.
  • a plurality of distinct nonoverlapping regions of wavelengths are incident upon a sample surface, diffusely reflected radiation is collected, and the analyte concentration is determined via chemometric techniques.
  • Specular reflectance R. Messerschmidt, D. Sting Blocker device for eliminating specular reflectance from a diffuse reflectance spectrum
  • U.S. patent no. 4,661 ,706 (April 28, 1987) describe a reduction of specular reflectance by a mechanical device.
  • a blade-like device "skims" the specular light before it impinges on the detector.
  • a disadvantage of this system is that it does not efficiently collect diffusely reflected light and the alignment is problematic.
  • R. Messerschmidt, M. Robinson Diffuse reflectance monitoring apparatus, U.S. patent no. 5,935,062 (August 10, 1999) and R. Messerschmidt, M. Robinson Diffuse reflectance monitoring apparatus, U.S. patent no. 6,230,034 (May 8, 2001) describe a diffuse reflectance control device that discriminates between diffusely reflected light that is reflected from selected depths. This control device additionally acts as a blocker to prevent specularly reflected light from reaching the detector. Malin, supra, describes the use of specularly reflected light in regions of high water absorbance, such as 1450 and 1900 nm, to mark the presence of outlier spectra wherein the specularly reflected light is not sufficiently reduced.
  • the arm sample site platform is moved along the z-axis that is perpendicular to the plane defined by the sample surface by raising or lowering the sample holder platform relative to the analyzer probe tip.
  • the '012 patent further teaches proper contact to be the moment specularly reflected light is about zero at the water bands about 1950 and 2500 nm.
  • Glycerol is a common index matching fluid for optics to skin.
  • the index-matching medium is a composition containing both perfluorocarbons and chlorofluorocarbons.
  • index-matching medium to improve the interface between the sensor probe and skin surface during spectroscopic analysis.
  • the index-matching medium is preferably a composition containing chlorofluorocarbons with optional added perfluorocarbons.
  • U.S. patent no. 6,381 ,489, April 30, 2002 describes a measurement condition setting fixture secured to a measurement site, such as a living body, prior to measurement. At time of measurement, a light irradiating section and light receiving section of a measuring optical system are attached to the setting fixture to attach the measurement site to the optical system.
  • J. Roper, D. Bocker, System and method for the determination of tissue properties U.S. patent no. 5,879,373 (March 9, 1999) describe a device for reproducibly attaching a measuring device to a tissue surface.
  • Optical sampling interface system for in-vivo measurement of tissue world patent publication no. WO 2003/105664 (filed June 11 , 2003) describe an optical sampling interface system that includes an optical probe placement guide, a means for stabilizing the sampled tissue, and an optical coupler for repeatably sampling a tissue measurement site in-vivo.
  • Rensen Catheter head WIPO publication no. WO 2004/093669 (filed April 23, 2004); and M. Van Beek, J. Horsten, M. Van Der Voort, G. Lucassen, P. Caspers, Method and apparatus for determining a property of a fluid which flows through a biological tubular structure with variable numerical aperture, WIPO publication no. WO 2005/009236 (filed July 26, 2004) describe a monitoring (targeting) system used to direct a Raman excitation system to a blood vessel.
  • Noninvasive A wide range of technologies serve to analyze the chemical make-up of the body. These techniques are broadly categorized into two groups, invasive and noninvasive. Herein, a technology is referred to as invasive if the measurement process acquires any biosample from the body for analysis or if any part of the measuring apparatus penetrates through the outer layers of skin into the body. Noninvasive procedures do not penetrate into the body or acquire a biosample outside of their calibration and calibration maintenance steps.
  • Coordinate system Herein, positioning and attitude are defined. Positioning is defined using a x-, y-, and z-axes coordinate system relative to a given body part. For example, an x,y,z-coordinate system is used to define the sample site, movement of objects about the sample site, changes in the sample site, and physical interactions with the sample site. A relative x-, y-, z- axes coordinate system is used to define a sample probe position relative to a sample site. The x-axis is defined along the length of a body part and the y- axis is defined across the body part.
  • the x-axis runs between the elbow and the wrist and the y-axis runs across the axis of the forearm.
  • the x-axis runs between the base and tip of the digit and the y-axis runs across the digit.
  • the z-axis is aligned with gravity and is perpendicular to the plane defined by the x- and y-axis.
  • the orientation of the sample probe relative to the sample site is defined in terms of attitude.
  • Attitude is the state of roll, yaw, and pitch.
  • Roll is rotation of a plane about the x-axis
  • pitch rotation of a plane about the y-axis
  • yaw is the rotation of a plane about the z-axis. Tilt is used to describe both roll and pitch.
  • the invention relates to a method and apparatus for performing noninvasive analyte property determination. More particularly, the invention relates to determining proximity and/or contact of an optical sample probe with skin tissue.
  • Figure 1 is a block diagram of a control system
  • Figure 2 is a block diagram of a qualification system
  • Figure 3 is a block diagram of a conductive contact system
  • Figure 4 provides an electrical schematic of a conductive contact system
  • Figure 5 is a flow diagram of a qualification / monitoring system
  • Figure 6 provides exemplary contact response data as a function of time/position
  • Figure 7 provides exemplary contact response data as a function of time/position
  • Figure 8 provides exemplary contact response data as a function of time/position
  • Figure 9 illustrates a sample probe configured with capacitive sensors
  • Figure 10 illustrates a first capacitive sensor probe circuit
  • Figure 11 illustrates a second capacitive sensor probe circuit
  • Figure 12 illustrates a sample probe tip configured with capacitive sensors.
  • the invention comprises a method and apparatus for directing proximate contact of a sample probe of a noninvasive analyzer or noninvasive spectrometer with a skin tissue sample.
  • a deformable matrix has fluid like properties that conforms to the shape of a contacting surface.
  • skin tissue conforms to the shape of a sample probe tip during a timescale of collecting a noninvasive scan, such as about one to sixty seconds with an applied pressure of less than 0.02 pounds per square inch.
  • TISSUE DISPLACEMENT CONTROL Displacement of the tissue sample by the sample probe results in changes in noninvasive spectra. Displacement of the sample tissue is related to pressure applied to the sample tissue. However, as the tissue is deformed the return force applied by the tissue sample to the sample probe varies. Therefore, it is preferable to discuss that sample / tissue interaction in terms of displacement instead of pressure.
  • Displacement of the tissue sample by the sample probe is preferably controlled between an insufficient and excessive displacement or pressure.
  • Insufficient contact of the sample probe with the tissue sample is detrimental.
  • the surface of the skin tends to be rough and irregular. Insufficient contact results in a surface reflection.
  • Contact between the sample probe and the tissue sample minimizes air pockets and reduces optical interface reflections that contain no useful information.
  • Contact or close proximity of the sample probe tip to the sample site preferably provides good optical transmission of source illumination into the capillary layer where the analytical signal exists while minimizing reflections from the surface of the skin that manifest as noise. Excessive displacement of the tissue sample by the sample probe is detrimental.
  • the primary region of interest for measurement of blood borne analytes is the capillary bed of the dermis region, which is approximately 0.1 to 0.4 mm beneath the surface.
  • the capillary bed is a compressible region and is sensitive to pressure, torque, and deformation effects.
  • the accurate representation of blood borne analytes that are used by the body through time, such as glucose, relies on the transport of blood to and from the capillary bed, so it is not preferable to restrict this fluid movement. Therefore, contact pressure/displacement is preferably minimal so as not to excessively restrict or to partially restrict for an extended period of time flow of blood and interstitial fluids to the sampled tissue region.
  • a tip of a sample probe is displaced less than about 0.1 millimeters into the deformable skin/tissue sample matrix.
  • two or more signals or signal types are used in the process of positioning a sample probe tip relative to a sample site.
  • a first signal is used to position the sample probe coarsely relative to the sample site and a second sensor is used to control sample probe positioning at a closer distance to the sample site.
  • a third sensor is used to still more finely position the sample probe tip relative to the sample site.
  • positioning is performed using one or more sensors.
  • Each of the sensors provides a distinct signal.
  • one sensor is based upon a vision system
  • a second uses a capacitance reading while a third is generated from a conductance and/or optical signal.
  • Different sensors are used for different levels of positioning. Generally as positioning goes from gross alignment to fine alignment:
  • This system allows for various sensors that are best used to estimate position of the sample probe at different distances from the sample site to be used serially or in a parallel fashion.
  • a first sensor is used for coarse alignment. Examples include:
  • the first sensor is used to bring the tip of the sample probe into a coarse position relative to the sample site.
  • the first sensor is for example used to move the sample probe in the range of about 0.2 to 10+ mm from the sample site. Examples of a targeting / vision system are provided, infra.
  • a second sensor such as a capacitance sensor, is optionally used with or without a first sensor.
  • the second sensor provides a signal distinct from the signal from the first sensor.
  • the second sensor is used to estimate distances of the sample probe tip to the sample site that are generally smaller than the first sensor, described supra.
  • the second sensor is used in positioning the sample probe in a range of about 0 to 1 mm from the sample site or ranges therein.
  • Examples of a capacitance sensor are described, infra.
  • An example of a third sensor is a conductance sensor.
  • a conductive sensor is used in positioning a sample probe tip at distances less than one-tenth of a millimeter from a sample tissue site.
  • Each of the sensor types are used individually or in combination.
  • a sample probe is placed near a sample site.
  • a capacitive sensor provides a time constant to the controller.
  • the controller uses the time constant to determine distance between the tip of the sample probe and the sample site.
  • the controller then sends a signal to one or more actuators that reposition the sample probe.
  • the capacitive sensor signaling process is iterated and the sample probe tip is moved toward the sample site.
  • two or more capacitive sensors yield corresponding time constants that are used by the controller to determine the tilt of the sample probe relative to the surface of the sample site.
  • the controller sends directions to one or more actuators to adjust the sample probe.
  • this second iterative process is repeated until the surface of the sample probe tip is about parallel to the sample site surface.
  • One or both of the first and second iterative processes are repeated either sequentially or in parallel.
  • a third sensor such as an optical sensor or a conductive sensor, yields a signal interpreted by the controller to yield a decision about fine movement of the sample probe relative to the sample site, typically in terms of z-axis position as tilt was previously adjusted.
  • This process iteratively uses optical signal to finely position the sample probe tip in contact with or in proximate contact with the sample site surface.
  • the first process uses sensor 1 to control z-axis position; the second process uses sensor(s) 2 to control the tilt of the sample probe relative to the tissue sample site; and the third process uses sensor 3 to finely position the sample probe tip into proximate contact or contact with the sample site.
  • a targeting / vision system is used to initially position a sensor relative to the sample site, such as in the x- and y- axes.
  • a second sensor is then used to adjust the probe, such as in tilt of the sample probe relative to a sample site and/or distance between the sample probe tip and the sample site.
  • a third sensor is used to finely control the sample probe tip, such as to proximate contact with, initial contact to, and/or displacement into a sample site.
  • a targeting system is used to position a measuring system, such as an optical probe of a noninvasive glucose concentration analyzer.
  • a targeting system targets a tissue area or volume of a sample.
  • a targeting system targets a surface feature, one or more volumes or layers, and/or an underlying feature, such as a capillary or blood vessel.
  • the measuring system preferably contains a sample probe, which is optionally separate from or integrated into the targeting system.
  • the sample probe of the measuring system is preferably directed to the targeted region or to a location relative to the targeted region either while the targeting system is active or subsequent to targeting.
  • a controller is used to direct the movement of the sample probe in at least one of the x-, y-, and z-axes via one or more actuators.
  • the controller directs a part of the analyzer that changes the observed tissue sample in terms of surface area or volume.
  • the controller communicates with the targeting system, measuring system, and/or controller.
  • a targeting system is further described, infra.
  • Controlled positioning of a tip of an optical probe with a skin tissue sample site is required for precise and accurate noninvasive analyte property determination, such as determination of glucose or urea concentration in blood and/or tissue.
  • analyte property determination such as determination of glucose or urea concentration in blood and/or tissue.
  • the tip of the optical probe is positioned in a manner allowing both the amount of collected specularly reflected light and the degree of sample probe movement induced change in the optically sampled tissue volume to not degrade analytical performance of the analyzer beyond acceptable error limits.
  • Control of a portion of an analyzer preferably uses a signal indicative of the relative distance between the optical probe tip and the skin tissue sample site.
  • signals are optionally used separately or in combination in positioning the optical probe relative to the sample site, including use of any of:
  • An example of an electrical signal is conductance and/or resistance between a voltage source and the skin tissue site, typically measured with a current flow.
  • Examples of optical signals include use of the optical signal used by the analyzer in determination of the analyte property and/or use of a visualization system, such as a camera. Further descriptions of electrical, optical, and capacitive sensors are provided, infra.
  • An algorithm controls the sample probe placement and/or orientation relative to a sample site in a dynamic and/or static fashion.
  • the sample probe tip relative to a sample site is controlled with respect to one or more of: • x-axis position; • y-axis position;
  • x- and y- axis positioning is used to sample the same location on a sample.
  • z-axis positioning is used to position the probes to ensure minimal collection of spectrally reflected light and/or to provide any of:
  • Tilt control is used to prevent excessive skin stretch when a flat surface, such as a sample probe tip or a guide, is brought into contact with a deformable sample site, such as tissue where tissue is often irregular and has generally non-flat measurement topology.
  • Tilt control allows the sensing portion of an sample probe, such as a center of an optical probe tip, to be brought into contact with a sample site without displacement and hence stretching of nearby skin by the edges of the optical probe as the sample probe tip is brought into contact at an angle normal to the irregular sample surface.
  • a contact, positioning, and/or contact sensor is used in control or positioning of analyzer relative to a tissue sample site.
  • a sample probe tip of the analyzer is positioned into proximate contact with the tissue sample site.
  • FIG 1 an example of a control loop 10 for an analyzer 11 is presented.
  • the analyzer has at least one part, such as a sample probe, that is moved into proximate contact or contact with a skin tissue sample 12.
  • One or more inputs 13 for controlling the position of the sample control include any of:
  • a vision sensor system 14 sensing a sample feature or sample topology
  • a transducer such as a mechanical to electrical transducer
  • a second optical system such as a laser distancing and/or ranging system
  • At least one of the sensor systems provides input to an algorithm 19 that directs an actuator 19 that moves the relative position of the skin tissue sample and the analyzer.
  • Each of contact or positioning sensors are optionally integrated into the analyzer or are external to the analyzer. Each of the contact or positioning sensors are further described, infra. QUALIFICATION
  • sample probe also referred to as a sample sensor probe
  • optical contact is not guaranteed but must be qualified. Acceptable optical contact is ascertained on the basis of one or more contact sensors, which surround or are in close proximity to the detection optic.
  • a signal is generated by the contact sensor which indicates a contact event. For example, a conductive contact is detected when the signal changes from its mean level by an amount greater than two times the standard deviation of the noise.
  • the contact event leads the controller into a new mode of operation involving collection of the spectroscopic information that is used to make the noninvasive measurement, which is used for analyte property determination.
  • the determination of the point at which the change in modes occurs is an important aspect of the invention and leads to superior quality of measurement.
  • two or more of the above named sensor types are used cooperatively in positioning the sample probe of the analyzer relative to the sample.
  • the various sensor systems are used in control of the motion of the sample probe at different distances between a tip of the sample probe and the tissue sample.
  • a target/vision system is used to find a tissue sample site to move the analyzer probe head toward, a capacitive sensor system is used to orient the tilt of the probe head to nominally match that of the skin surface at the sample site, the capacitive sensor is further used in positioning the sample probe head close to the sample site, and a conductive sensor system is used in fine positioning of the tip of the sample probe headed to distances of less than a tenth of a millimeter and preferably about a hundredth of a millimeter from the tissue sample site.
  • a conductive sensor system is used in fine positioning of the tip of the sample probe headed to distances of less than a tenth of a millimeter and preferably about a hundredth of a millimeter from the tissue sample site.
  • a sensor probe of an analyzer 31 is positioned manually or through use of an actuator 10.
  • a sensor position reading 22 and/or a noninvasive optical reading 23 are collected.
  • the sensor position reading is optionally collected before, concurrently with, and/or after the noninvasive optical reading.
  • one or both of the sensor position reading and the noninvasive optical reading 24 are used to reposition the sensor probe using the actuator 19.
  • the noninvasive reading is qualified for use in any of: a calibration model 25 and used for predicting 25 and analyte property.
  • a vision system 14 provides gross alignment
  • a capacitive sensor system 16 provides fine alignment
  • a conductive sensor system 17 output is used to control very fine positioning of the sample probe, such as at distances of less than about 0.1 millimeter.
  • a conductive contact sensing system 30 is used that includes at least a power supply 31 , such as a voltage source, replaceably interfaced to a skin tissue sample 12.
  • the voltage source is preferably a low voltage source, such as a source providing about 1 , 3, 6, or 12 volts.
  • the voltage is converted to a current carried over one or more electrical conduits 33, 34 through an power meter
  • the circuit is initially open and is closed when the electrical conduits 33, 34 are brought into contact with the skin tissue 12, such as through one or more connections 36, 37.
  • current flows from the power source 31 to the skin through a first electrical conduit 33 and through a contacting element 36, such as a tip of a sample probe of an analyzer.
  • a contacting element 36 such as a tip of a sample probe of an analyzer.
  • current returns to the voltage source via a separate electrical conduit 34, such as a conducting line.
  • the first and second contacting elements 36, 37 are optionally contained in one housing or in two housings.
  • the current entering the skin tissue sample 32 completes an electrical circuit by passing to ground from the skin, the power supply also being grounded.
  • a change in current is observed when the circuit is completed.
  • the circuit is completed when the relative distance between the contacting element 36 and skin tissue 12 is reduced to a contacting distance of less than about 0.1 millimeter and typically to a distance of less than about 0.01 millimeters.
  • the power supply 31 such as a bias voltage of about six volts
  • the power supply 31 is an input to an operational amplifier 41.
  • the voltage is converted to current across a resistor 42, such as resistor of about 100 MOhm resistance.
  • a resistor 42 such as resistor of about 100 MOhm resistance.
  • the observed current is compared with the bias current using a differential amplifier 44 and the resulting signal is converted to a voltage at an analog to digital converter 45.
  • the bias current is filtered using a low pass filter 43, such as a 2.5 Hertz low pass filter.
  • a flowchart of an example of use of a sample probe 40 is provided.
  • tissue movement 51 of the sample relative to the sample probe is performed.
  • the sample probe is moved 41 and contact between the sample probe and tissue sample is sought 42 using a contact sensor, such as any described herein.
  • This process is iterative or the sensing signal is sought while the sample probe is moved.
  • acquisition of data commences.
  • data is additionally acquired as contact between the sample probe and tissue sample is sought.
  • a contact qualification monitoring system 50 is used to determine contact or proximate contact of the sensor system with a tissue sample.
  • the conductive sensor provides a feedback signal to a controlling algorithm or actuator telling the analyzer when to stop moving the sample probe.
  • Spectral data is acquired is acquired during the contact sensing process and/or after contact is established.
  • the contact sensing process is also referred to herein as a hunt process.
  • the conductive sensor system acts as a system for monitoring continued contact. If contact is lost, the analyzer is preferably directed to reestablish contact between the optical probe and the tissue sample.
  • the spectral data acquisition system, conductive contact determination/monitoring system, and actuator movement system are optionally used serially, iteratively, and/or in parallel with each other.
  • a current monitored contact event between an analyzer and a skin tissue sample is demonstrated.
  • a sample probe of an analyzer is moved toward a skin tissue sample as a function of time.
  • a response of a conductive contact sensor is provided as the sample probe moves.
  • a bias voltage from an analog to digital converter is obtained, which is nominally flat as a function of time.
  • the observed voltage rises rapidly to a new level.
  • the returned voltage stabilizes at a new level. Both the slope of the rising response curve and the difference between the initial and final observed voltages are indicative of the contacting event.
  • the high slope between the bias and stabilized voltage is indicative of the contact event occurring over a short time period.
  • the difference is indicative of the quality of the contact and also of the state of the skin tissue. For example, a fully hydrated skin sample will yield a larger difference than a poorly hydrated skin sample.
  • the current magnitude also provides information about the contact event, such as a coupling fluid thickness between the skin and the probe. For instance, since FC-40 has a high resistance, the observed contact current increases as the thickness of the FC40 layer on the skin decreases.
  • Figure 7 illustrates the conductive contact event as a tip of the sample probe is moved into contact with skin tissue.
  • the slope of the rising response curve is illustrative of conductive contact being made over a longer time period, such as occurs when the skin sample stretches as the tip of the sample probe hits the skin surface.
  • the sample probe further displaces the tissue before a stabilized contact is obtained.
  • Selection of later optical samples collected when the electrical contact is stabilizing with acceptable contact allows calibration and/or prediction using the optical samples where good contact between the sample probe and skin tissue sample is present. This process yields samples with smaller changes in optically sampled tissue volume as a function of time.
  • the selection of samples based upon the electrical contact sensor response thus leads to selection of prediction samples bounded by calibration data, thereby leading to more robust, accurate, and precise analyte property estimations.
  • the use of one or more contact responses in selection of corresponding optical samples for use in calibration and/or prediction is further described, infra.
  • the use of the conductive contact response in selection of corresponding optical samples for use in calibration and/or prediction is beneficial. For instance, only optical samples having full contact are selected for calibration and/or prediction. Alternatively, samples are selected having any contact, such as samples having a conductive contact response greater than the initial bias voltage plus two times the noise of the initial non- contacting samples.
  • the use of conductive contact is also useful data in determining validity of an optical contact metric, as described infra.
  • FIG 8 yet another example of a conductive contact sensor response is provided.
  • the tip of an optical sample probe configured with a conductive contact sensor, is moved toward a skin tissue sample. Initially, no contact is made. At sample number eighteen initial contact is made; full contact is made within a few additional samples. The observed voltage response of the conductive contact sensor subsequently fell due to loss of contact. Falling contact voltages result from a number of scenarios, such as skin movement, skin slipping or sagging relative, or perturbation of the sample by the probe.
  • the sample probe tip was repositioned and the conductive contact sensor indicates when contact is reestablished after moving the probe, such as by monitoring the response voltage until movement of the sample probe brings the response back up to a contact level meeting specification or to a full contact level. In this case, the sample probe was moved toward the skin to regain full contact.
  • a current-measurement contact sensor is placed adjacent to or surrounding an optical detection fiber.
  • a metal tube can surround the optical fiber and the contact sensor uses the tube for its measurement interface.
  • the tip of optical collection means such as the end of a fiber optic, is also making contact and the measurement may be made.
  • the tip of the sample probe is preferably driven into the tissue sample along the z-axis a small amount, such as about 25 to 200 ⁇ m, in order to ensure the probe is in contact with the skin throughout the duration of the measurement.
  • sensors are placed at away from the center of the tip of the sample probe.
  • the circumferentially distributed contact sensors are used to indicate when the probe comes down at an angle and a corner of the tip of the sample probe contacts the skin tissue before the center of the sample probe.
  • These contact sensors are optionally in a ring that indicates contact at any point around the probe or are sensors that indicate contact at specific locations, such as at corners or edges of the tip sample probe.
  • sensors are placed along each of the axial, y-axis, and longitudinal axis, x-axis of a body part so that the phasing of the sensors contacting in time may be analyzed to help interpret the geometry changes occurring during the contact event.
  • a single circuit is preferably multiplexed with multiple sensors to minimize the amount of additional cabling required with additional sensors.
  • a current reading from a given sensor is be taken before contact to establish a baseline.
  • the current is periodically monitored during a measurement sweep and more frequently as the probe approaches the arm in order to prevent a crash into skin due the probe stopping too late.
  • the contact-current is compared to the intensity at about 1290 or about 1450 nm returning from the arm or to capacitance measurements to assess the approach of the probe to the arm and slow its descent as necessary.
  • a conductive sensor around the perimeter of the optical detection fiber is used to identify measurements and scans within a dynamic measurement that have intimate contact between the skin and the optical detection fiber. Such a sensor is used to control the dynamics of probe contact and/or to select the scans with the most intimate contact for use in calibration and for qualifying prediction spectra.
  • CAPACITIVE SENSOR / CAPACITANCE PROBE CONTROL In yet another embodiment of the invention, capacitance sensors or touch sensors are used for determining any of:
  • a capacitive sensor is used to adjust tilt of the sample probe relative to the sample site tissue morphology and/or in positioning of the tip of the sample probe in close proximity to the tissue sample.
  • a conductive sensor as described supra, is used for determining contact and/or for positioning of the tip of the sample probe from distances of -0.05 to 0.1 mm from the nominal position of the skin tissue surface.
  • Figure 9A is a side view of a sample module having a sample probe 902 having a sample probe tip 903 illustrated relative to a tissue sample or sample site.
  • the sample probe 902 is illustrated with an optional collection optic 904, and two halves of two separate capacitance conductors 905, 906.
  • An end view of the sample probe 902 is illustrated in Figure 9B.
  • the circuit 1001 used to determine proximity of a subject's sample site to the sample probe includes a capacitor 1002 and a first resistor 1003.
  • the capacitance, C is calculated according to equation 1 , a
  • capacitance, C is proportional to the area, A, of the capacitor divided by the distance, d, between the capacitor plates.
  • the capacitor has two plates.
  • the first capacitor plate 1004 is integrated or connected to the sample module, preferably the sample module sample probe tip.
  • the second capacitor 1005 is the deformable material, such as a skin sample, body part, or a the tissue sample site. The assumption is that the person is a capacitor.
  • a typical adult has a capacitance of about 120 pF. Capacitance of different people or kids will vary.
  • the time constant, T is equal to the resistance, R, times the capacitance.
  • the distance between the capacitor plates is calculated through the combination of equations 1 and 2 through the measurement of the circuit time constant.
  • the time constant is the time required to trip a set voltage level, such as about 2.2 volts, given a power supply of known power, such as about 3.3 volts.
  • the time constant is used to calculate the capacitance using equation 2.
  • the capacitance is then used to calculate the distance or relative distance through equation 1. For example, as a distance between a sample site, such as a forearm or digit of a hand, and the capacitor plate decreases, the time constant increases and the capacitance increases.
  • the measure of distance is used in positioning the probe at or in proximate contact with the sample site without disturbing the sample site as described, infra.
  • a second circuit 1101 using the capacitance 1002 / resistor 1003 combination of the first circuit is enhanced to amplify the signal to noise using an operational amplifier 1102 and a second resistor 1103.
  • the gain of the circuit is the ratio of the first resistor 1103 and the second resistor 1103.
  • the voltage between the wire leading to the operation amplifier and a surrounding tube/shell is held at or about zero to minimize parasitic capacitance of the long wire and/or to minimize changes in capacitance caused by changes in the environment.
  • a microprocessor used to measure the time constant is attached to any of the circuits herein described.
  • the distance or relative distance between the sample probe tip and the sample site is determined, preferably before the tip of the sample probe displaces localized sample site skin/tissue which, as described supra, can lead to degradation of the sample integrity in terms of collected signal-to-noise ratios and /or sampling precision. Examples are used to illustrate the use of the capacitance sensor in the context of a noninvasive analyte property determination.
  • the distance or relative distance between the sample probe tip and the sample site is determined using a single capacitor.
  • the sample probe is brought into close proximity with the sample site using the time constant/distance measurement as a metric. In this manner, the sample probe is brought into close proximity to the sample site without displacing the sample site. Due to the inverse relationship between capacitance and distance, the sensitivity to distance between the sample site and the sample probe increases as the distance between decreases.
  • the distance between the sample site and the tip of the sample probe is readily brought to a distance of less than about one millimeter. Capacitance sensors as used herein can also readily be used to place the sample probe tip with a distance of less than about 0.1 millimeter to the sample site.
  • a conductance sensor is subsequently used in positioning the sample probe tip at distances less than one-tenth of a millimeter from the undisturbed tissue sample site surface.
  • multiple capacitors are optionally used to yield more than one distance reading between the sample probe tip and the sample site.
  • Multiple capacitive sensors are optionally used to control tilt along x- and/or y- axes.
  • Two or more capacitance sensors are optionally used for leveling the tip of the sample probe relative to the morphology of the sample site.
  • the distance between the sample site and the probe tip is measured using two or more capacitor pairs.
  • Figure 11 shows a first and second capacitor plate in the sample probe tip. If one capacitor reads a larger distance to the sample site than the second capacitor, then the probe tip is moved to level the probe by moving the larger distance side toward the sample, the smaller distance side away from the sample, or both.
  • the sample probe tip tilt or angle is either moved manually or by mechanical means, described infra.
  • exemplary capacitance layouts on the tip of a sample probe are provided.
  • four capacitance sensors 1201-1204 are used allowing for detection of tilt along the x-, y-, or x and y-axis by comparison of signal strength between two or more of the four sensors 1201-1204.
  • signals from two or more capacitors are combined, such as via a summation or an addition.
  • signals from sensors 1201 and 1202 are combined and compared against the combined signals of sensors 1203 and 1204.
  • the combined signals are used as a feedback to a controller controlling tilt, such as along the y-axis.
  • four capacitance based sensors are placed at or near the surface of a probe tip.
  • the sensors are placed along the x- and y-axis for ease in determining x- and y-axis level of the sensor probe.
  • two capacitance sensors 1201 , 1203 are shown off axis on a round sample probe tip.
  • five capacitance sensors 1201-1205 are shown that vary in position along a single direction, the x-axis as shown. As orientated, the five sensors are used to detect tilt of the sample probe relative to the sample site and/or proximity of the sample probe tip to the sample site.
  • any number of capacitance sensors are used in any geometric configuration on, near, or within a sample probe tip of any geometry.
  • Capacitive sensors have multiple advantages including: cost, response time, weight, size, and sensitivity.
  • the capacitance sensors are optionally embedded into the sample probe tip providing a dielectric barrier between the sensor and the subject, which is beneficial in terms of safety requirements, such as government regulatory requirements.
  • an optical sensor such as an infrared sensor, is used to detect distance between a sample probe tip and a sample, tilt of a sample probe relative to a sample, and/or contact or proximate contact of a sample probe tip with a sample site.
  • the optical sensors are optionally configured in the orientation of any of the above described orientations of the capacitance proximity sensors, such as at or near the edges of the sample probe tip.
  • Each of the optical sensors includes an illumination source and a detector.
  • the source is optionally independent for each sensors, such as through one or more light emitting diodes. Alternatively, two of more of the sensors share a common source, such as a single light emitting diode or an incandescent source, such as a tungsten halogen lamp.
  • the detectors are optionally placed within the sample probe tip, near the sample probe tip, or at a distance from the sample probe tip. In the later case, light is coupled to the detector via optics, such as fiber optics.
  • the optical sensors are preferably used to detect contact or near contact of the sample probe tip with the sample through the use of over absorbed wavelengths in human tissue, such as about 1450 nm where the surface reflection intensity dominates over signal returning via scattering from within the tissue sample.
  • the sample probe is moved down the z-axis until the specular light approaches zero. Movement of the sample probe is as described using the capacitance sensor and includes movement under manual control or automated control with or without the use of one or more actuators and with or without a feedback sensor and controller.
  • a second mode as surface reflection intensity is known to be a function of distance, the surface intensities from two or more optical sensors are compared in order to determine relative tilt of the sample probe relative to the tissue sample and the information used to adjust tilt until near tangential contact is achieved.
  • the optical signal from the source of the analyzer that is detected by the detector used to generate a signal for subsequent an analyte property determination, is used to determine proximity to or contact of the sample probe tip with the sample site. For instance, the spectrum determined using photons gathered by the collection fiber is used to determine proximity of or contact of the sample probe with the tissue sample site.
  • An illustrative example of an optical probe is provided. Photons from a source are reflected off of a backreflector through a first optic and through a second optic to a sample, such as skin.
  • the first optic is optionally used to remove unwanted emanating photons from the source that would otherwise optically heat the sample.
  • the second optic passes light and is optionally used to stabilize any of: sample site topology, sample site hydration, and to mechanically stabilize or locate a collection optic, such as a fiber optic.
  • detectors are used to detect light from the sensor source in order to control tilt of the sample probe relative to the sample and/or distance between the tip of the fiber optic and the sample.
  • a machine vision system 14 is used in determining a sample site and/or in reproducibly targeting a sample site, such as a determined sample site.
  • the targeting system and measuring system optionally use a single source that is shared or have separate sources.
  • the targeting is optionally used to first target a region and the measuring system subsequently samples at or near the targeted region.
  • the targeting and measuring system are used over the same period of time so that targeting is active during sampling by the measuring system.
  • the targeting system and measuring system optionally share optics and/or probe the same tissue area and/or volume.
  • the targeting and measuring system use separate optics and/or probe different or overlapping tissue volumes.
  • neither, one, or both of the targeting system and measuring system are brought into contact with the skin tissue at or about the sample site.
  • Targets include any of:
  • tissue morphology • tissue morphology; • a target below the skin surface;
  • marking features added to the skin include a tattoo, one or more dyes, one or more reflectors, a crosshair marking, and positional markers, such as one or more dots or lines.
  • a skin surface feature include a wart, hair follicle, hair, freckle, wrinkle, and gland.
  • Tissue morphology includes surface shape of the skin, such as curvature and flatness.
  • specifications for a dermis thickness include a minimal thickness and a maximum depth.
  • the target is a volume of skin wherein the analyte, such as glucose, concentration is higher.
  • the measuring system is directed to image photons at a depth of the enhanced analyte concentration.
  • a targeting system targets a target.
  • a targeting system typically includes a controller, an actuator, and a sample probe.
  • Examples of targeting systems include a planarity detection system, optical coherence topography (OCT), a proximity detector and/or targeting system, an imaging system, a two-detector system, and a single detector system.
  • Examples of targeting system technology include impedence, acoustic signature, ultrasound, use of a pulsed laser to detect and determine distance, and the use of an electromagnetic field, such as radar and high frequency radio-frequency waves.
  • Sources of the targeting system include a laser scanner, ultrasound, and light, such as ultraviolet, visible, near-infrared, mid-infrared, and far- infrared light.
  • Detectors of the targeting system are optionally a single element, a two detector system, an imaging system, or a detector array, such as a charge coupled detector (CCD) or charge injection device or detector (CID).
  • CCD charge coupled detector
  • CID charge injection device or detector
  • One use of a targeting system is to control movement of a sample probe to a sampling location.
  • a x second example of use of a targeting system is to make its own measurement.
  • a third use is as a primary or secondary outlier detection determination. In its broadest sense, one or more targeting systems are used in conjunction with or independently from a measurement system.
  • mid- infrared light samples surface features to the exclusion of features at a depth due to the large absorbance of water in the mid-infrared.
  • a second example uses the therapeutic window in the near-infrared to image a feature at a depth within tissue due to the light penetration ability from 700 to 1100 nm. Additional examples are targeting with light from about 1100 to 1450, about 1450 to 1900, and/or about 1900 to 2500 nm, which have progressively shallower penetration depths of about 10, 5, and 2 mm in tissue, respectively.
  • a further example is use of visible light for targeting or imaging greater depths, such as tens of millimeters.
  • Raman targeting system such as in WIPO international publication number WO 2005/009236 (February 3, 2005), which is incorporated herein in its entirety by this reference thereto.
  • a Raman system is capable of targeting capillaries. Multiple permutations and combinations of optical system components are available for use in a targeting system.
  • a controller controls the movement of one or more sample probes via one or more actuators.
  • the controller optionally uses an intelligent system for locating the sample site and/or for determining surface morphology. For example, the controller hunts in the x- and y-axes for a spectral signature.
  • the controller moves a sample probe via the actuator toward or away from the sample along the z-axis.
  • the controller optionally uses feedback from the targeting system, from the measurement system, or from an outside sensor in a closed-loop mechanism for deciding on targeting probe movement and for sample probe movement.
  • the controller optimizes a multivariate response, such as response due to chemical features or physical features.
  • Examples of chemical features include blood/tissue constituents, such as water, protein, collagen, elastin, and fat.
  • physical features include temperature, pressure, and tissue strain. Combinations of features are used to determine features, such as specular reflectance.
  • specular reflectance is a physical feature optionally measured with a chemical signature, such as water absorbance bands centered at about 1450, 1900, or 2600 nm.
  • Controlled elements include any of the x-, y-, and z-axis position of sampling along with rotation or tilt of the sample probe. Also optionally controlled are periods of light launch, intensity of light launch, depth of focus, and surface temperature.
  • the controller controls elements resulting in pathlength and/or depth of penetration variation.
  • the controller controls an iris, rotating wheel, backreflector, or incident optic, which are each described infra.
  • the controller moves the targeting probe and/or sample probe so as to make minimal and/or controlled contact with the sample to control stress and/or strain on the tissue, which is often detrimental to a noninvasive analyte property estimation.
  • Strain is the elongation of material under load. Stress is a force that produces strain on a physical body. Strain is the deformation of a physical body under the action of applied force. In order for an elongated material to have strain there must be resistance to stretching. For example, an elongated spring has strain characterized by percent elongation, such as percent increase in length.
  • Skin contains constituents, such as collagen, that have spring-like properties. That is, elongation causes an increase in potential energy of the skin. Strain induced stress changes optical properties of skin, such as absorbance and scattering. Therefore, it is not desirable to make optical spectroscopy measurements on skin with varying stress states. Stressed skin also causes fluid movements that are not reversible on a short timescale. The most precise optical measurements are therefore conducted on skin in the natural strain state, such as minimally or non-stretched stretched skin. Skin is stretched or elongated by applying loads to skin along any of the x-, y-, and z- axes, described infra. Controlled contact reduces stress and strain on the sample. Reducing stress and strain on the sample results in more precise sampling and more accurate and precise glucose concentration estimations.
  • the displacement of the tissue sample by the sample probe results in compression of the sample site.
  • the displacement results in a number of changes including at least one of:
  • An example of using light to measure a physical property, such as contact, stress, and/or strain, in tissue is provided.
  • Incident photons are directed at a sample and a portion of the photons returning from the sample are collected and detected.
  • the detected photons are detected at various times, such as when no stress is applied to the tissue and when stress is applied to the tissue. For example, measurements are made when a sample probe is not yet in contact with the tissue and at various times when the sample probe is in contact with the tissue, such as immediately upon contact and with varying displacement of the sample probe into the tissue.
  • the displacement into the tissue is optionally at a controlled or variable rate.
  • the collected light is used to determine properties.
  • One exemplary property is establishing contact of the sample probe with the tissue.
  • a second exemplary property is strain.
  • Changes in the ratio are indicative of hydration.
  • data collection routines are varied depending upon the determined state of the tissue.
  • the probing tissue displacement is varied with change in hydration.
  • the strain measurement is optionally made with either the targeting system or measurement system.
  • the tissue state probe describe herein is optionally used in conjunction with a dynamic probe, described infra.
  • a coupling fluid is applied between the tip of the sample probe and the tissue sample site. It is determined that highly viscous coupling fluid degrade the noninvasive analyte determination system.
  • a highly viscous coupling fluid requires increased pressure to be applied between the tip of a sample probe and a tissue sample site in order to displace the viscous coupling fluid.
  • Fluorolube is a viscous paste that is not readily displaced. The pressure required for the tip of the sample probe to displace the Fluorolube results in tissue stress and strain that degrades the analytical quality of the noninvasive signal. Therefore, less viscous coupling fluids are required, such as FC-70 or FC-40.
  • the viscosity of the coupling fluid should not exceed that of FC-70 and preferably the viscosity of the coupling fluid should not exceed that of FC-40.
  • an analyzer comprises at least a source coupled via optics to a detector.
  • the analyzer is handheld.
  • the analyzer sits upon a supporting surface during use.
  • the analyzer is split having a base module physically separated from the sample module, where the sample module interfaces with the sample site during operational use.
  • the base module is connected to the sample module via wireless communication, is connected via a communication bundle, or is connected through a semi-rigid weight support system, where the weight support system serves to support at least a portion of the weight of the sample module during use.
  • the weight support system preferably operates as an automated positioning system or an actuation system.
  • the communication bundle preferably carries any of: optical signal, data signal, power, electrical control signal, and a fluid between the base module and the sample module.
  • the weight support system carries any of:
  • the analyzer is preferably a split analyzer where the weight support system additionally operates as a communication bundle.
  • optical components such as a source; backreflector; guiding optics; lenses; filters; mirrors; a wavelength separation device; and at least one detector, are optionally positioned in the base module and/or sample module.
  • the noninvasive analyzer contains a base module interfaced to a sample module.
  • the base module is any of:
  • the sample module interfaces with a sample.
  • Means for analyzing collected data, such as spectra and subject data are preferably contained within or coupled to the base module.
  • any of the embodiments described herein are operable in a home environment, public facility, or in a medical environment, such as an emergency room, critical care facility, intensive care unit, hospital room, or medical professional patient treatment area.
  • the split analyzer is operable in a critical care facility where the sample module is positioned in proximate contact with a subject or patient during use and where the base module is positioned on a support surface, such as a rack, medical instrumentation rack, table, or wall mount.
  • At least a portion of the sample module is movable with respect to a subject or patient sample site along any of the x-, y- , and z-axes, and/or in terms of rotation or tilt.
  • the sample site such as a forearm remains stationary while at least a portion of the analyzer, such as the sample probe head, moves to interface with the sample in terms of an X-, y-, and/or z-axis and/or with respect to rotation or tilt.
  • the components defining the optical train of an analyzer are moved as a unit to reposition the sample probe tip relative to a sample site.
  • Moving the optical units of an analyzer together allows for fixed optics or optics with tighter constraints in terms of movement than a fiber optic. For instance moving the sample probe head to the sample does not change the collection optic pathway so that collection optics can spatially fixed or controlled in terms of optically coupling the tip of the fiber bundle to the detection element.
  • optics in the optical train from the sample to the detector are moved together in a controlled fashion.
  • the analyzer is held in a fixed position while the tissue sample site is moved relative to the analyzer by moving a body part, such as with an adjustable platform, along any of the x-, y-, and z-axes, and/or in terms of rotation or tilt.
  • the movable portion of the sample module moves in an active or passive manner.
  • a controller is preferably used to position the tip of the sample probe relative to a tissue sample site.
  • a command input is sent to an actuator system within the analyzer, where the actuator system is preferably in the sample module.
  • the actuator system controls the position of a probe system having a sensor. The position is relative to a sample site.
  • the signal from the sensor is either used in the measurement of an analyte property value of the sample or is used as input for a controller that sends additional input to the actuator system to further control position or movement of the probe system via the actuator system.
  • the actuator system preferably contains electronics used in conjunction with electro-mechanical conversion of the movable aspect of the analyzer, such as the tip of the probe system within the sample module in terms of one or more of: x-position, y-position, z-position, tilt, and rotation of the sample probe tip relative to the sample site.
  • Movement of the sample probe is preferably performed using an electro- mechanical converter.
  • an actuator system is preferably controlled using a controller provided with signal from the probe system sensor. For example, if a capacitance sensor indicates that the probe tip is too far from the sample, an electro-mechanical converter is used to translate the sample probe along the z-axis toward the sample site. Similarly, if two capacitance signals from opposite sides of the sample probe tip indicate that the sample probe tip is not normal to the sample site, then one or more actuators are used to adjust the tilt of the sample probe or the level of the sample probe tip relative to the sample site surface. In one case, one or more sensors are used in combination with one or more actuators to control sample probe position in terms of any of:
  • a partial vacuum is optionally applied at or near the sample site.
  • the partial vacuum pulls the skin into full contact with the sample probe tip.
  • a benefit of this system is ease of use.
  • a second benefit is that it allows the skin to have twitching movement without altering the optical sample site.
  • the probe contact event is complicated by fluid drag properties that include contact inconsistencies in the contact at the measurement interface.
  • One potential is for the development of liquid lensing of the optical fluid in the low pressure area near the optical detection fiber.
  • Feature extraction is used to qualify optical contact between a tip of a sample probe of an analyzer and a tissue sample.
  • the contact event of the measurement process is difficult to determine using optical methods as an optical signal used is a mixture of light that has been diffusely reflected from the arm and light that has been reflected from the arm as a first-surface reflector. This, along with dynamic nature of the skin makes it difficult to assign an absolute threshold that designates when contact has occurred.
  • noninvasive spectra of human tissue contain features related to chemical and physical structures of the sampled tissue.
  • the response signal in a region that is scattering dominated increases in magnitude while the response signal in a region that is absorbance dominated decreases in value, such as at about 1450 nm.
  • the ratio of two features or the change in direction of a magnitude of a feature as a function of distance between the sample probe and the tissue sample is an indicator of sample contact and is used to qualify the invention.
  • the interface to the skin tissue and related deformation is dependent upon the orientation of the contact surface to the skin tissue and the approach angle of the device probe as it contacts and deforms the skin.
  • the problem is related to the necessity for optical contact between the probe optics and the skin surface. This contact is achieved by moving the optical interface into contact with skin surface and optionally displacing skin tissue as the point of optical contact recedes in response to the presence of the probe.
  • a portion of the probe is likely to displace a greater portion of the skin tissue than desired, leading to a change in the scattering and absorption properties of the targeted measurement site.
  • the displacement and/or stretch of the tissue caused by a mismatch of the tissue surface and optical interface may lead to a push of interstitial fluid away from the point of measurement and/or a plastic deformation of the skin tissue. Both effects increase the level of spectral interference and reduce the signal to noise ratio of the measurement system.
  • the problem is especially severe in the case of a probe system which controls the z-axis (movement to and from the skin) on the basis of optical contact.
  • the actuator system may displace a significant volume of tissue in an effort to achieve the desired optical contact.
  • the problem is exacerbated with the angle between the probe surface and skin varies from sample to sample. In this case both the scattering properties of the skin are varied in addition to effects related to tissue displacement.
  • Adjustment of the angle between the probe surface and the skin tissue measurement site is accomplished either through a change in the orientation of the subject's body position, an in particular, the orientation of their forearm to the probe surface, the adjustment of the probe itself relative to the surface of the targeted point of measurement, the determination of a point of contact possessing a parallel point relative to the optical interface of the probe surface, or the tissue measurement site.
  • the probe is relatively stationary and the subject's forearm is adjusted to achieve a measurement angle that is within the desired limits (plus or minus one degree). This is accomplished by a rotation of the arm and height adjustments of the subject's hand/wrist and elbow support systems.
  • a hand/wrist and elbow support system is set up for a subject in a manner that achieves a near tangent point of measurement.
  • adjustments to the measurement angle are made by changing the angle of the subject's hand/wrist support system.
  • the adjustments are made either manually by the patient on the basis of a display providing directions or through an automated feedback control system which detects the measurement angle through proximity sensors and directs an actuator to modify the angle of the wrist/hand support system.
  • the probe itself is adjusted to achieve a small measurement angle.
  • the desired point of measurement has been located using criteria other than the measurement angle and therefore necessitate an adjustment of the probe to .
  • the measurement angle is reduced by changing the orientation of the measurement probe itself.
  • a targeting system is employed to achieve a reproducible measurement site using either an adjustable forearm support system or an adjustable probe positioning system.
  • actuators are used, on the basis of the estimated measurement angle, to change the orientation of the probe itself such that a tangent point of contact occurs and optionally a z-axis displacement that is perpendicular to the probe surface.
  • a point of tangency (measurement angle close to zero) is used to set the point of measurement by using a search algorithm on the basis of forearm topology.
  • the topology of the forearm is determined using an imaging system and a point of tangency determined by locating the measurement point extremum.
  • the topology of the forearm is mapped in the vicinity of the desired measurement site using proximity sensors. The measurement site is again determined as that point in which the slope relative to the probe surface is zero. In particular, on the bottom of the forearm the lowest point is determined as the point of measurement.
  • the forearm can be mapped by moving proximity sensors across the surface or hunted for by repeatedly mapping a small region.
  • the point of measurement is hunted for using a feedback control system which adjusts the x-y position of the probe on the basis of the measurement angle.
  • the error in the measurement angle is used to direct movement of the probe in either x and/or y directions until either a suitable measurement angle is achieved or a failure occurs (actuator moves beyond x-y bounds).
  • a proximity sensor can be moved closed to the skin surface in the vicinity of the desired measurement site.
  • the measurement angle in both the x and y axis is determined.
  • the probe is then repeatedly moved in the direction that is likely to reduce the measurement angle. Specifically, the probe is moved in the direction opposite of the measurement angle.
  • the magnitude of movement may be fixed, it has been determined to be more efficient to adjust the movement step size on the basis of both the measurement angle and prior adjustments and/or measurement angles in a manner similar to a gradient descent or conjugate gradient descent optimizer or alternately, a proportional- integral-derivative (PID) controller.
  • PID proportional- integral-derivative
  • the tissue volume itself is mechanically controlled or constrained in a manner that achieves a low measurement angle.
  • Optical spectroscopic measurements of living human skin are used to calibrate an instrument to measure blood glucose concentration noninvasively.
  • n surface roughness of skin and the optical index of refraction
  • surface reflections lead to the rise of nonlinear stray light type effects. That is nonlinear effects result from incident light that is reflected off the sample and measured instead of being transmitted into the sample and diffusely reflected and measured.
  • calibration models are built using data of a specified sample probe / tissue contact level. For example, highly contacting samples are used in a first calibration, mid-level contacting samples are used in a second calibration, and low-level contacting samples are used in a third calibration. Prediction spectra are subsequently classified into a contacting specification and applied to the corresponding calibration model.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

L'invention concerne un procédé et un appareil pour effectuer une détermination de propriété d'analyte non invasive. Plus particulièrement, l'invention concerne la détermination d'une proximité et/ou d'un contact d'une sonde d'échantillon optique avec un tissu cutané.
EP07863843A 2006-11-03 2007-11-02 Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané Withdrawn EP2077750A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86437506P 2006-11-03 2006-11-03
PCT/US2007/083497 WO2008058014A2 (fr) 2006-11-03 2007-11-02 Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané

Publications (2)

Publication Number Publication Date
EP2077750A2 true EP2077750A2 (fr) 2009-07-15
EP2077750A4 EP2077750A4 (fr) 2010-03-31

Family

ID=39365265

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07863843A Withdrawn EP2077750A4 (fr) 2006-11-03 2007-11-02 Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané

Country Status (2)

Country Link
EP (1) EP2077750A4 (fr)
WO (1) WO2008058014A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9468379B2 (en) 2010-04-21 2016-10-18 Koninklijke Philips N.V. Determination of a lipid water ratio
US20150245782A1 (en) * 2014-02-28 2015-09-03 Covidien Lp Systems and methods for capacitance sensing in medical devices
EP3244348A1 (fr) 2014-10-15 2017-11-15 Eccrine Systems, Inc. Sécurité et conformité de communication de dispositif de détection de transpiration
CN107567302A (zh) * 2015-02-24 2018-01-09 外分泌腺系统公司 动态汗液传感器管理
US10646142B2 (en) 2015-06-29 2020-05-12 Eccrine Systems, Inc. Smart sweat stimulation and sensing devices
US20180317833A1 (en) 2015-10-23 2018-11-08 Eccrine Systems, Inc. Devices capable of fluid sample concentration for extended sensing of analytes
US10674946B2 (en) 2015-12-18 2020-06-09 Eccrine Systems, Inc. Sweat sensing devices with sensor abrasion protection
US10531818B2 (en) 2016-01-18 2020-01-14 Erasmus University Medical Center Rotterdam Tissue sample analysis
US11690541B2 (en) * 2016-06-28 2023-07-04 Kevin Hazen Tissue state classifier for noninvasive glucose concentration determination analyzer apparatus and method of use thereof
EP3487390A4 (fr) 2016-07-19 2020-03-11 Eccrine Systems, Inc. Conductivité de la sueur, taux de sudation volumétrique et dispositifs de réponse galvanique de la peau et applications
US10736565B2 (en) 2016-10-14 2020-08-11 Eccrine Systems, Inc. Sweat electrolyte loss monitoring devices
EP3505048A1 (fr) * 2017-12-28 2019-07-03 Koninklijke Philips N.V. Capteur optique de peau utilisant des bandes spectrales optimales pour minimiser l'effet de la pression sur le capteur

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050267342A1 (en) * 2004-04-28 2005-12-01 Blank Thomas B Noninvasive analyzer sample probe interface method and apparatus
WO2006091911A2 (fr) * 2000-05-02 2006-08-31 Sensys Medical, Inc. Capteur de prelevement servant d'interface conçu pour un analyseur non invasif, et procede correspondant
WO2007087529A2 (fr) * 2006-01-23 2007-08-02 Sensys Medical, Inc. Procédé et dispositif pour commander le déplacement d'une sonde d'échantillon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE246356T1 (de) * 1998-05-13 2003-08-15 Cygnus Therapeutic Systems Vorrichtung zum vorhersagen von physiologischen messwerten
US6980852B2 (en) * 2002-01-25 2005-12-27 Subqiview Inc. Film barrier dressing for intravascular tissue monitoring system
US7697966B2 (en) * 2002-03-08 2010-04-13 Sensys Medical, Inc. Noninvasive targeting system method and apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091911A2 (fr) * 2000-05-02 2006-08-31 Sensys Medical, Inc. Capteur de prelevement servant d'interface conçu pour un analyseur non invasif, et procede correspondant
US20050267342A1 (en) * 2004-04-28 2005-12-01 Blank Thomas B Noninvasive analyzer sample probe interface method and apparatus
WO2007087529A2 (fr) * 2006-01-23 2007-08-02 Sensys Medical, Inc. Procédé et dispositif pour commander le déplacement d'une sonde d'échantillon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008058014A2 *

Also Published As

Publication number Publication date
WO2008058014A3 (fr) 2008-08-21
EP2077750A4 (fr) 2010-03-31
WO2008058014A2 (fr) 2008-05-15

Similar Documents

Publication Publication Date Title
US20080033275A1 (en) Method and Apparatus for Sample Probe Movement Control
US8868147B2 (en) Method and apparatus for controlling positioning of a noninvasive analyzer sample probe
WO2008058014A2 (fr) Procédé et appareil pour une détection non invasive de contact sonde/tissu cutané
US7697966B2 (en) Noninvasive targeting system method and apparatus
US20060217602A1 (en) Method and apparatus for noninvasive targeting
US7299080B2 (en) Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy
US7519406B2 (en) Noninvasive analyzer sample probe interface method and apparatus
US6990364B2 (en) Noninvasive measurement of glucose through the optical properties of tissue
US20060211931A1 (en) Noninvasive analyzer sample probe interface method and apparatus
US6675029B2 (en) Apparatus and method for quantification of tissue hydration using diffuse reflectance spectroscopy
US20150018646A1 (en) Dynamic sample mapping noninvasive analyzer apparatus and method of use thereof
US20040127777A1 (en) Indirect measurement of tissue analytes through tissue properties
US20050119541A1 (en) Method of adapting in-vitro models to aid in noninvasive glucose determination
US20050187439A1 (en) Sampling interface system for in-vivo estimation of tissue analyte concentration
AU2002249985A1 (en) Noninvasive measurement of glucose through the optical properties of tissue
US20050107676A1 (en) Method and apparatus for noninvasive glucose concentration estimation through near-infrared spectroscopy
WO2005046441A2 (fr) Methode d'adaptation de modeles in vitro afin de faciliter une determination glucosique non invasive

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090504

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SLAWINSKI, CHRISTOPHER

Inventor name: BLANK, THOMAS B.

Inventor name: WELCH, JAMES M.

Inventor name: RUCHTI, TIMOTHY L.

Inventor name: MONFRE, STEPHEN L.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100529